PJSIMP
CELG

P.J. Schmidt Investment Management (PJS)’s Celgene Corp CELG Stock Holding History

P.J. Schmidt Investment Management (PJS)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,515
Closed -$221K – 140
2017
Q3 		$221K Buy
+1,515
New +$206K 0.07% 126
2017
Q2 		– Sell
-1,615
Closed -$201K – 131
2017
Q1 		$201K Buy
+1,615
New +$193K 0.07% 119
2016
Q1 		– Sell
-2,070
Closed -$248K – 146
2015
Q4 		$248K Buy
+2,070
New +$239K 0.1% 128
2015
Q1 		– Sell
-1,900
Closed -$213K – 162
2014
Q4 		$213K Buy
+1,900
New +$200K 0.08% 142

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

P.J. Schmidt Investment Management (PJS)'s CELG Position: Q4 2017 in Review

P.J. Schmidt Investment Management (PJS) sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,515 shares — an estimated $221K sold.

P.J. Schmidt Investment Management (PJS) first reported a position in CELG in Q4 2014 and held it in 4 quarters. The position peaked at $248K in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • P.J. Schmidt Investment Management (PJS) reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • P.J. Schmidt Investment Management (PJS) sold 1,515 Celgene Corp shares in Q4 2017, an estimated $221K.
  • P.J. Schmidt Investment Management (PJS) first reported a position in Celgene Corp in Q4 2014 and held it in 4 quarters.
  • P.J. Schmidt Investment Management (PJS)'s Celgene Corp position peaked at $248K in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q4 2017, filed 30 Jan 2018.